Cargando…
Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments
Pantothenate Kinase-Associated Neurodegeneration (PKAN) is an autosomal recessive disorder characterized by a mutation in the PANK2 gene. The clinical presentation may range from only speech disorder to severe generalized dystonia, spasticity, Visual loss, dysphagia and dementia. The hallmark of thi...
Autores principales: | Razmeh, Saeed, Habibi, Amir Hassan, Orooji, Maryam, Alizadeh, Elham, Moradiankokhdan, Karim, Razmeh, Behroz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937219/ https://www.ncbi.nlm.nih.gov/pubmed/29844889 http://dx.doi.org/10.4081/ni.2018.7516 |
Ejemplares similares
-
A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients
por: Rohani, Mohammad, et al.
Publicado: (2018) -
A novel homozygous variation in the PANK2 gene in two Persian siblings with atypical pantothenate kinase associated neurodegeneration
por: Habibi, Amir Hasan, et al.
Publicado: (2019) -
Treatment of Levodopainduced dyskinesia with Vitamin D: A Randomized, double-blind, placebo-controlled trial
por: Habibi, Amir Hassan, et al.
Publicado: (2018) -
Stiff person case misdiagnosed as conversion disorder: A case report
por: Razmeh, Saeed, et al.
Publicado: (2017) -
Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction?
por: Almasi, Mostafa, et al.
Publicado: (2016)